- Trials with a EudraCT protocol (513)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
513 result(s) found for: Bone infection.
Displaying page 1 of 26.
EudraCT Number: 2012-003690-25 | Sponsor Protocol Number: PI2012_843_0008 | Start Date*: 2013-01-23 | |||||||||||
Sponsor Name:CHU Amiens | |||||||||||||
Full Title: | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-015744-42 | Sponsor Protocol Number: NA | Start Date*: 2009-12-03 |
Sponsor Name:Oxford Radcliffe Hospitals Trust | ||
Full Title: Randomized open label study of oral versus intravenous antibiotic treatment for bone and joint infections requiring prolonged antibiotic treatment: Preliminary study in a single centre. | ||
Medical condition: Bone and joint infection including; o Osteomyelitis. o Septic arthritis. o Prosthetic joint associated infection o Orthopaedic device associated infection o Discitis/ epidural abscess | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2021-001708-14 | Sponsor Protocol Number: ABOGRAFT-01 | Start Date*: 2021-06-29 |
Sponsor Name:Region Östergötland | ||
Full Title: Antibiotic Impregnated Bone Graft to reduce infection in hip replacement. The ABOGRAFT trial | ||
Medical condition: Patients scheduled for any type of hip arthroplasty requiring bone grafting | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2014-004961-26 | Sponsor Protocol Number: 12-009 | Start Date*: 2015-12-15 | |||||||||||||||||||||||||||||||||||||||||
Sponsor Name:McMaster University | |||||||||||||||||||||||||||||||||||||||||||
Full Title: Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY): A Multi-Center Randomized Controlled Study Comparing Alternative Antibiotic Regimens in Patients Undergoing Tumor Resections with Endopro... | |||||||||||||||||||||||||||||||||||||||||||
Medical condition: ? Patients with a primary bone malignancy or soft-tissue sarcoma that has invaded a lower extremity bone that are undergoing surgical treatment to resect the tumor and functionally reconstruct the ... | |||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||
Trial protocol: ES (Ongoing) AT (Completed) | |||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001906-41 | Sponsor Protocol Number: CHUBX2019/24 | Start Date*: 2021-06-16 |
Sponsor Name:CHU DE BORDEAUX | ||
Full Title: Benefit of positons emission tomography / 68Gallium citrate tomodensitometry for artificial hip and knee chronic infection diagnosis | ||
Medical condition: joint prosthesis infection | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: FR (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2014-004819-37 | Sponsor Protocol Number: APART_2014 | Start Date*: 2015-04-16 | |||||||||||
Sponsor Name:University College Dublin | |||||||||||||
Full Title: A multi-centre, prospective, randomised trial of short course alendronate therapy or placebo combined with vitamin D and calcium to prevent loss of bone mineral density in antiretroviral-naïve, HIV... | |||||||||||||
Medical condition: Human immunodeficiency virus (HIV) infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Completed) DK (Prematurely Ended) GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-005011-73 | Sponsor Protocol Number: PI2019_843_0018 | Start Date*: 2020-03-11 |
Sponsor Name:CHU Amiens-Picardie | ||
Full Title: Determination of a trough serum concentration of ofloxacin associated to increase in side effects frequency in elderly treated for bone and joint infection | ||
Medical condition: bone and joint infection | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-004939-39 | Sponsor Protocol Number: GS-EU-174-1403 | Start Date*: 2015-05-26 | |||||||||||
Sponsor Name:Gilead Sciences International Ltd. | |||||||||||||
Full Title: Pharmacoepidemiology study to define the long-term safety profile of tenofovir disoproxil fumarate (Tenofovir DF, Viread®) and describe the management of Tenofovir DF-associated renal and bone toxi... | |||||||||||||
Medical condition: Chronic Hepatitis B | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) GB (Prematurely Ended) ES (Prematurely Ended) BG (Prematurely Ended) GR (Completed) FR (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-000602-10 | Sponsor Protocol Number: PID13859 | Start Date*: 2022-07-12 | ||||||||||||||||||||||||||||||||||||
Sponsor Name:Oxford University Hospitals NHS Foundation Trust | ||||||||||||||||||||||||||||||||||||||
Full Title: Short or Long Antibiotic Regimes in Orthopaedics (SOLARIO): A Randomised Open Label Multi-Centre Clinical Trial | ||||||||||||||||||||||||||||||||||||||
Medical condition: Orthopaedic infections, including chronic osteomyelitis and prosthetic joint infection) needing prolonged courses of antibiotics (6 weeks or more)and also surgical treatment | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||
Trial protocol: ES (Ongoing) | ||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-003745-40 | Sponsor Protocol Number: GS-IT-131-0151 | Start Date*: 2005-02-07 | |||||||||||
Sponsor Name:GILEAD SCIENCES S.R.L. | |||||||||||||
Full Title: Phase II pilot study on safety of administration of 3mg/kg/day three times a week until day 22 (21 days after transplantation day) and 7 mg/kg weekly from day 29 to the end of treatment ( day 50-8t... | |||||||||||||
Medical condition: Fungal Infection High risk patients undergoing allogeneic stem-cell transplantation. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-001358-84 | Sponsor Protocol Number: 1708212 | Start Date*: 2018-10-12 | |||||||||||
Sponsor Name:CHU de Saint Etienne | |||||||||||||
Full Title: Bone, Inflammation, Gut and Renal Biomarkers in Antiretroviral Naïve HIV-1 positive subjects commencing Antiretroviral Therapy | |||||||||||||
Medical condition: HIV-positive subjects initiating antiretroviral therapy | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-021242-22 | Sponsor Protocol Number: PHRN09-LB / DATIPO | Start Date*: 2011-07-26 | |||||||||||
Sponsor Name:CHRU de Tours | |||||||||||||
Full Title: Etude multicentrique, de non infériorité, randomisée, ouverte, évaluant l’efficacité de deux Durées d’Antibiothérapie (6 semaines versus 12 semaines) dans le Traitement des Infections sur Prothèses... | |||||||||||||
Medical condition: Infection sur prothèse ostéo-articulaire | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-005192-14 | Sponsor Protocol Number: HLS03/2012 | Start Date*: 2013-01-31 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA L. SACCO (A.O. DI RILIEVO NAZIONALE) | |||||||||||||
Full Title: Strategic study of dual-therapy with darunavir/ritonavir and rilpivirine QD versus triple-therapy in patients with suppressed viral load: virological efficacy and evaluation of non-HIV related morb... | |||||||||||||
Medical condition: HIV infection. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-006716-30 | Sponsor Protocol Number: 128/2006/O/Sper | Start Date*: 2006-12-19 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI | |||||||||||||
Full Title: Randomized, controlled, multicentric trial to evaluate efficacy and safety of the switch from a LPV/r based therapy to an ATV/r or a NVP based treatment in association with ABC/3TC, in HIV patient ... | |||||||||||||
Medical condition: HIV infection | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-004564-26 | Sponsor Protocol Number: BAS20 | Start Date*: 2021-09-20 | |||||||||||
Sponsor Name:Karolinska Institute | |||||||||||||
Full Title: Role of antibiotics in conjunction with oral bone augmentation procedures (BAS20) | |||||||||||||
Medical condition: Patients requiring bone augmentation procedure prior to, or in conjunction to installation of dental implants. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-002257-76 | Sponsor Protocol Number: 3074K5-319-WW | Start Date*: 2006-12-20 | |||||||||||
Sponsor Name:Wyeth Research Division of Wyeth Pharmaceuticals Inc. | |||||||||||||
Full Title: A Multicenter, Randomized, Double-Blind, Comparison Study of the Safety and Efficacy of a Once-Daily Dose of Tigecycline versus Ertapenem for the Treatment of Foot Infections in Subjects with Diabetes | |||||||||||||
Medical condition: Subjects with diabetes with a qualifying foot infection. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) BE (Completed) SE (Prematurely Ended) LT (Completed) SK (Completed) FI (Completed) GB (Completed) LV (Completed) PT (Completed) EE (Completed) FR (Completed) AT (Completed) GR (Completed) DE (Completed) IT (Prematurely Ended) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-006153-41 | Sponsor Protocol Number: J&P004/2008 | Start Date*: 2009-03-30 |
Sponsor Name:Medical university Graz, Department of Plastic Surgery | ||
Full Title: Target site pharmacokinetics of linezolid after repetitive doses in diabetic patients with bacterial foot infection | ||
Medical condition: The study population will consist of a representative group of adult male or female patients with documented diabetes and bacterial soft tissue infection of the foot complicated by osteomyelitis. P... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-006146-34 | Sponsor Protocol Number: 100505 | Start Date*: 2008-04-30 |
Sponsor Name:Stage Pharmaceuticals GmbH | ||
Full Title: Adoptive Immunotherapy of chemotherapy refractory CMV infections using Streptamer-isolated T cells after allogeneic bone marrow or peripheral blood stem cell transplantation: a phase I/II trial | ||
Medical condition: -chronic persistent CMV infection after allogeneic bone marrow or peripheral blood stem cell transplantation, refractory to antiviral chemotherapy | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2017-001327-45 | Sponsor Protocol Number: 69HCL17_0226 | Start Date*: 2017-09-04 | |||||||||||
Sponsor Name:Hospices Civils de Lyon | |||||||||||||
Full Title: A pilot study of Ceftobiprole diffusion in bone and joint, in patients with BIJ( bone and joint infection) undergoing hip or knee replacement. | |||||||||||||
Medical condition: Bone or joint Infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-019060-37 | Sponsor Protocol Number: CH.MAX-FACC.02/2009 | Start Date*: 2010-07-09 | ||||||||||||||||
Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI | ||||||||||||||||||
Full Title: Clinical prospective study to evaluate the efficacy of hygienical therapy and metronidazole in addition to antibiotic therapy in patients affected by bisphosponate-associated osteonecrosis of the jaws | ||||||||||||||||||
Medical condition: patients affected by bisphosponate-associated osteonecrosis of the jaws and infection. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Completed) | ||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
